Sign Up to like & get
recommendations!
0
Published in 2018 at "Oncogene"
DOI: 10.1038/s41388-018-0171-x
Abstract: The RAS–RAF–MEK–ERK signaling cascade is among the most frequently mutated pathways in human cancer. Approximately 50% of melanoma patients possess a druggable hotspot V600E/K mutation in the BRAF protein kinase. FDA-approved combination therapies of BRAF…
read more here.
Keywords:
braf alterations;
braf;
cancer;
non v600 ... See more keywords